Regulation & law · 25/10/1995
FDA Announces Public Workshop on Characterization of Biological/Biotechnology Pharmaceutical Products
The FDA is hosting a public workshop to discuss the data needed to ensure the safety and quality of biological/biotechnology pharmaceuticals, and to explore the capabilities of current analytical technologies.
Original source language: Federal Register — All DocumentsOpen original release →